In the full patient cohort, T/PSA remained a statistically significant predictor of prostate cancer after adjusting for age, PSA density (PSAD), and prostate volume (OR = 0.10, 95% CI: 0.01–0.79, p = 0.029). This evidence concerns the gene KLK3 and prostate carcinoma.